X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-23 | SGMT | Kemble George | Exec COB | S - Sale | $3.17 | -23,625 | 118,693 | -17% | -$74,830 | ||||||
2024-07-19 | SGMT | Martins Eduardo Bruno | Chief Medical Officer | S - Sale | $3.10 | -8,357 | 81,213 | -9% | -$25,910 | ||||||
2024-07-19 | SGMT | Rozek Elizabeth | GC, CCO | S - Sale | $3.10 | -10,914 | 160,506 | -6% | -$33,830 | ||||||
2024-07-19 | SGMT | Kemble George | Exec COB | S - Sale | $3.10 | -14,062 | 142,318 | -9% | -$43,605 | ||||||
2024-03-26 | SGMT | Happel David | Pres, CEO | P - Purchase | $5.27 | +12,100 | 639,200 | +2% | +$63,731 | ||||||
2023-12-07 | SGMT | Happel David | Pres, CEO | P - Purchase | $4.10 | +1,600 | 627,100 | 0% | +$6,560 | ||||||
2023-11-16 | SGMT | Happel David | Pres, CEO | P - Purchase | $2.35 | +590 | 590 | New | +$1,387 | ||||||
| D | 2023-07-18 | SGMT | New Enterprise Associates 13 LP | 10% | S - Sale+OE | $16.00 | -662 | 3,850,275 | 0% | -$10,592 | |||||
| D | 2023-07-18 | SGMT | New Enterprise Associates 13 LP | 10% | P - Purchase | $16.00 | +30,000 | 3,850,275 | +1% | +$480,000 | |||||
| D | 2023-07-18 | SGMT | Seidenberg Beth C | Dir | P - Purchase | $16.00 | +46,875 | 2,031,118 | +2% | +$750,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |